Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for premenstrual syndrome
RBR-6pmz49Phase 3Recruiting
- Sponsor
- Hospital das Clínicas de Ribeirão Preto
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluoxetine in premenstrual syndrome (PMS) (4 arms), sponsored by Hospital das Clínicas de Ribeirão Preto. Started May 2017; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on RBR-6pmz49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6pmz49.